Christopher M. O’Connor
ORCID：0000-0002-1076-718X
发表论文 1207 篇 · 总被引 80072 次 · h-index 140
代表论文
- Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 77)
- Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 39)
- Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF (2025 · Journal of the American College of Cardiology · 被引 19)
- Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial (2025 · European Heart Journal · 被引 19)
- Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy (2025 · Circulation Heart Failure · 被引 5)
- Two-year outcomes in the direct oral anticoagulant apixaban in left ventricular assist devices (DOAC LVAD) study (2025 · The Journal of Heart and Lung Transplantation · 被引 5)